A detailed history of Quadrature Capital LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Quadrature Capital LTD holds 59,890 shares of ABT stock, worth $6.84 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
59,890
Previous 102,995 41.85%
Holding current value
$6.84 Million
Previous $10.7 Billion 36.21%
% of portfolio
0.15%
Previous 0.18%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $4.31 Million - $5.09 Million
-43,105 Reduced 41.85%
59,890 $6.83 Billion
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $10.4 Million - $11.6 Million
102,995 New
102,995 $10.7 Billion
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $2.03 Million - $2.27 Million
20,173 New
20,173 $2.2 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $16.7 Million - $19.6 Million
-175,620 Reduced 96.15%
7,025 $771,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $10.8 Million - $12.5 Million
111,645 Added 157.25%
182,645 $17.7 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $1.94 Million - $2.35 Million
19,008 Added 36.56%
71,000 $7.73 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $2.53 Million - $3.09 Million
22,196 Added 74.49%
51,992 $6.16 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $3.44 Million - $4.21 Million
29,796 New
29,796 $4.19 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $1.08 Million - $1.27 Million
-10,180 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $4.71 Million - $5.55 Million
-43,286 Reduced 80.96%
10,180 $1.22 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $3.69 Million - $4.02 Million
35,125 Added 191.51%
53,466 $5.86 Million
Q1 2020

Apr 10, 2024

BUY
$62.82 - $91.86 $486,729 - $711,731
7,748 New
7,748 $611,000
Q2 2018

Aug 10, 2018

BUY
$57.57 - $63.54 $1.06 Million - $1.17 Million
18,341 New
18,341 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.